Association between a history of comorbidities and the use of complementary and alternative medicine to prevent COVID-19

Authors

  • Percy Herrera-Añazco Universidad Privada San Juan Bautista, Lima, Perú
  • Carlos J. Toro-Huamanchumo Unidad de Investigación para la Generación y Síntesis de Evidencias en Salud, Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Perú
  • Médico Cirujano Nuñez-Tarazona Universidad Privada San Juan Bautista, Lima, Perú
  • Olenka Farfán-Zapata Universidad Privada San Juan Bautista, Lima, Perú

DOI:

https://doi.org/10.35434/rcmhnaaa.2024.171.2046

Keywords:

Complementary Therapies, Medicine Traditional, Plants Medicinal, Coronavirus Infections, Primary Prevention

Abstract

Objective: To evaluate the association between a history of comorbidities and the use of complementary and alternative medicine (CAM) to prevent COVID-19 in Lambayeque, Peru. Material and Methods: Analytical cross-sectional study that used information from the database of the Red Prestacional Lambayeque of the Social Security of Health. The outcome variable was the self-report of having consumed and/or used some type of MAC during the pandemic to prevent COVID-19. The main independent variable was the self-reported history of having any comorbidity. Sociodemographic and clinical confounding variables were included. To assess the association of interest, crude (PRc) and adjusted (PRa) prevalence ratios were calculated using Poisson regression models with robust variances. Results: A total of 243 participants with a history of COVID-19 were surveyed. Most were male (54.7%), and the median age was 29 [25-59] years. 29.2% used CAM to prevent COVID-19. In the adjusted model, a history of comorbidity increased the probability of CAM use (PR: 1.55; 95% CI: 1.05 – 2.28; p: 0.028). Conclusions: A history of comorbidity was associated with a higher probability of CAM consumption during the COVID-19 pandemic in adults to prevent SARS-CoV-2 infection.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biographies

Percy Herrera-Añazco, Universidad Privada San Juan Bautista, Lima, Perú

1. Médico Cirujano.

Carlos J. Toro-Huamanchumo, Unidad de Investigación para la Generación y Síntesis de Evidencias en Salud, Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Perú

1. Médico Cirujano

Médico Cirujano Nuñez-Tarazona, Universidad Privada San Juan Bautista, Lima, Perú

1. Médico Cirujano

Olenka Farfán-Zapata, Universidad Privada San Juan Bautista, Lima, Perú

1. Médico Cirujano

References

Harris PE, Cooper KL, Relton C, Thomas KJ. Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. Int J Clin Pract. octubre de 2012;66(10):924-39. Doi:10.1111/j.1742-1241.2012.02945.x. PMID: 22994327.

Kim TH, Kang JW, Jeon SR, Ang L, Lee HW, Lee MS. Use of Traditional, Complementary and Integrative Medicine During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 9 de mayo de 2022;9:884573. Doi:10.3389/fmed.2022.884573. PMID: 35615091; PMCID: PMC9125211.

Bao Y, Kong X, Yang L, Liu R, Shi Z, Li W, et al. Complementary and alternative medicine for cancer pain: an overview of systematic reviews. Evid Based Complement Alternat Med. 2014;2014:170396. Doi:10.1155/2014/170396. PMID: 24817897; PMCID: PMC4003746.

Hu J, Shi W, Xu J, Liu S, Hu S, Fu W, et al. Complementary and Alternative Medicine for the Treatment of Abnormal Endometrial Conditions in Women with PCOS: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evid Based Complement Alternat Med. 29 de abril de 2021;2021:5536849. Doi:10.1155/2021/5536849. PMID: 34012472; PMCID: PMC8105096.

Soltani A, Jaam M, Nazar Z, Stewart D, Shaito A. Attitudes and beliefs regarding the use of herbs and supplementary medications with COVID-19: A systematic review. Res Social Adm Pharm. noviembre de 2022;S1551-7411(22)00393-X. Doi:10.1016/j.sapharm.2022.11.004

Badakhsh M, Dastras M, Sarchahi Z, Doostkami M, Mir A, Bouya S. Complementary and alternative medicine therapies and COVID-19: a systematic review. Rev Environ Health. 27 de septiembre de 2021;36(3):443-50. Doi:10.1515/reveh-2021-0012. PMID: 33838089.

Mezones-Holguin E, Amaya E, Bellido-Boza L, Mougenot B, Murillo JP, Villegas-Ortega J, et al. Cobertura de aseguramiento en salud: el caso peruano desde la Ley de Aseguramiento Universal. Revista Peruana de Medicina Experimental y Salud Pública. 25 de junio de 2019;196-206. Doi:10.17843/rpmesp.2019.362.3998.

Luján-Carpio E, Lizarraga-Castañeda Z, Mayor-Vega A, Medrano-Canchari K, Medina-Salazar H, Goicochea-Lugo S. El servicio de Medicina complementaria de EsSalud, una alternativa en el sistema de salud peruano. Revista Medica Herediana. 25 de junio de 2014;25(2):105-105. Doi: 10.20453/rmh.v25i2.255.

Santiváñez-Acosta R, Valenzuela-Oré F, Angulo-Bazán Y, Santiváñez-Acosta R, Valenzuela-Oré F, Angulo-Bazán Y. Uso de terapias de medicina alternativa y complementaria en la provincia de Coronel Portillo, Ucayali, Perú. Revista Peruana de Medicina Experimental y Salud Publica. julio de 2020;37(3):510-5. Doi:10.17843/rpmesp.2020.373.4939.

Peralta-Vera FG, Castillo-Céspedes E, Galup-Leyva M, Rucoba-Ames J, Herrera-Añazco P, Benites-Zapata VA. Factors Associated with Home Remedy Use by Adults Who Do Not Attend Health Care Facilities: Evidence from Peruvian Population-based Survey, 2019. J Health Care Poor Underserved. 2021;32(4):2110-24. Doi:10.1353/hpu.2021.0185

Herrera-Añazco P, Taype-Rondan A, Ortiz PJ, Málaga G, Del Carpio-Toia AM, Alvarez-Valdivia MG, et al. Use of medicinal plants in patients with chronic kidney disease from Peru. Complement Ther Med. diciembre de 2019;47:102215. Doi:10.1016/j.ctim.2019.102215.

Oblitas G, Hernández-CórdovaG G, Chiclla A, Antich-Barrientos M, Ccorihuamán-Cusitito L, Romaní F. Use of medicinal plants among people attending two reference hospitals in Cuzco, Peru. Rev Peru Med Exp Salud Publica. 2013;30(1):64-68. Doi:10.1590/s1726-46342013000100013.

Herrera-Añazco P, Uyen-Cateriano A, Mezones-Holguin E, Taype-Rondan A, Mayta-Tristan P, Malaga G, et al. Some lessons that Peru did not learn before the second wave of COVID-19. Int J Health Plann Manage. mayo de 2021;36(3):995-8. Doi:10.1002/hpm.3135.

Pesantes MA, Lazo-Porras M, Cárdenas MK, Diez-Canseco F, Tanaka-Zafra JH, Carrillo-Larco RM, et al. Los retos del cuidado de las personas con diabetes durante el estado de emergencia nacional por la COVID-19 en Lima, Perú: recomendaciones para la atención primaria. Rev Peru Med Exp Salud Publica. 2020;37(3):541-546. Doi:10.17843/rpmesp.2020.373.5980.

Málaga G. Causas de admisión en el Hospital Cayetano Heredia durante la pandemia de COVID-19. Rev Peru Med Exp Salud Publica. 2 de diciembre de 2020;37:587-8. Doi:10.17843/rpmesp.2020.373.5868.

Herrera-Añazco P, Valenzuela-Rodríguez G, Torres-Pesantes L, Toro-Huamanchumo CJ. Desabastecimiento de antidiabéticos y antihipertensivos en el contexto de la etapa inicial de la pandemia por la COVID-19 en Perú. Rev. Cuerpo Med. HNAAA. 2021;14(Supl. 1):22-7. Doi:10.35434/rcmhnaaa.2021.14Sup1.1152.

Villena-Tejada M, Vera-Ferchau I, Cardona-Rivero A, Zamalloa-Cornejo R, Quispe-Florez M, Frisancho-Triveño Z, et al. Use of medicinal plants for COVID-19 prevention and respiratory symptom treatment during the pandemic in Cusco, Peru: A cross-sectional survey. PLOS ONE. 22 de septiembre de 2021;16(9):e0257165. Doi:10.1371/journal.pone.0257165.

Dadras O, SeyedAlinaghi S, Karimi A, Shamsabadi A, Qaderi K, Ramezani M, et al. COVID-19 mortality and its predictors in the elderly: A systematic review. Health Sci Rep. mayo de 2022;5(3):e657. Doi:10.1002/hsr2.657.

Péterfi A, Mészáros Á, Szarvas Z, Pénzes M, Fekete M, Fehér Á, et al. Comorbidities and increased mortality of COVID-19 among the elderly: A systematic review. Physiol Int. 16 de mayo de 2022; Doi:10.1556/2060.2022.00206.

Valladares-Garrido MJ, Failoc-Rojas VE, Soto-Becerra P, Zeña-Ñañez S, Torres-Roman JS, Fernández-Mogollón JL, et al. Clinical-epidemiologic variation in patients treated in the first and second wave of COVID-19 in Lambayeque, Peru: A cluster analysis. Int J Infect Dis. octubre de 2022;123:212-20. Doi:10.1016/j.ijid.2022.07.045.

Su BB, Ma JX, Song W, Yuan J, Dong XY, Wan J. Analysis of comorbidity and polypharmacy in middle-aged and elderly patients. Zhonghua Yi Xue Za Zhi. 7 de julio de 2020;100(25):1983-7. Doi:10.3760/cma.j.cn112137-20200403-01066.

Arabyat RM, Alazzam OM, Al-Azzam SI, Nusair MB. Association between Charlson Comorbidity Index and polypharmacy: a retrospective database study from Jordan. Int J Pharm Pract. 4 de diciembre de 2021;29(6):580-6. Doi:10.1093/ijpp/riab067.

Rodrigues MCS, Oliveira C de. Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review. Rev Lat Am Enfermagem. 1 de septiembre de 2016;24:e2800. Doi:10.1590/1518-8345.1316.2800.

Kohl-Heckl WK, Schröter M, Dobos G, Cramer H. Complementary medicine use and flu vaccination - A nationally representative survey of US adults. Vaccine. 15 de septiembre de 2021;39(39):5635-40. Doi: 10.1016/j.vaccine.2021.08.017.

Ruiz-Padilla AJ, Alonso-Castro AJ, Preciado-Puga M, González-Núñez AI, González-Chávez JL, Ruiz-Noa Y, et al. Use of allopathic and complementary medicine for preventing SARS-CoV-2 infection in Mexican adults: A national survey. Saudi Pharm J. septiembre de 2021;29(9):1056-60. Doi: 10.1016/j.jsps.2021.07.009.

Charan J, Bhardwaj P, Dutta S, Kaur R, Bist SK, Detha MD, et al. Use of Complementary and Alternative Medicine (CAM) and Home Remedies by COVID-19 Patients: A Telephonic Survey. Indian J Clin Biochem. enero de 2021;36(1):108-11. Doi:10.1007/s12291-020-00931-4.

Staples LG, Dear BF, Gandy M, Fogliati V, Fogliati R, Karin E, et al. Psychometric properties and clinical utility of brief measures of depression, anxiety, and general distress: The PHQ-2, GAD-2, and K-6. Gen Hosp Psychiatry. 2019;56:13-8. Doi:10.1016/j.genhosppsych.2018.11.003.

Arrieta J, Aguerrebere M, Raviola G, Flores H, Elliott P, Espinosa A, et al. Validity and Utility of the Patient Health Questionnaire (PHQ)-2 and PHQ-9 for Screening and Diagnosis of Depression in Rural Chiapas, Mexico: A Cross-Sectional Study. J Clin Psychol. septiembre de 2017;73(9):1076-90. Doi: 10.1002/jclp.22390.

García-Campayo J, Zamorano E, Ruiz MA, Pérez-Páramo M, López-Gómez V, Rejas J. The assessment of generalized anxiety disorder: psychometric validation of the Spanish version of the self-administered GAD-2 scale in daily medical practice. Health Qual Life Outcomes. 19 de septiembre de 2012;10:114. Doi: 10.1186/1477-7525-10-114.

Herrera-Añazco P, Uyen-Cateriano Á, Urrunaga-Pastor D, Bendezu-Quispe G, Toro-Huamanchumo CJ, Rodríguez-Morales AJ, et al. Prevalence and factors associated with the intention to be vaccinated against COVID-19 in Peru. Rev Peru Med Exp Salud Publica. 1 de julio de 2021;38(3):381-90. Doi: 10.17843/rpmesp.2021.383.7446.

Dehghan M, Ghanbari A, Ghaedi Heidari F, Mangolian Shahrbabaki P, Zakeri MA. Use of complementary and alternative medicine in general population during COVID-19 outbreak: A survey in Iran. J Integr Med. enero de 2022;20(1):45-51. Doi:10.1016/j.joim.2021.11.004.

Lam CS, Koon HK, Chung VCH, Cheung YT. A public survey of traditional, complementary and integrative medicine use during the COVID-19 outbreak in Hong Kong. PLOS ONE. 1 de julio de 2021;16(7):e0253890. Doi:10.1371/journal.pone.0253890.

Mulder LTC, Busch M, Kristoffersen AE, Hök Nordberg J, van der Werf ET. Prevalence and predictive factors of complementary medicine use during the first wave of the COVID-19 pandemic of 2020 in the Netherlands. BMC Complementary Medicine and Therapies. 15 de febrero de 2022;22(1):43. Doi: 10.1186/s12906-022-03528-x.

Herrera-Añazco P, Urrunaga-Pastor D, Benites-Zapata VA, Bendezu-Quispe G, Toro-Huamanchumo CJ, Hernandez AV. COVID-19 symptomatology and compliance with community mitigation strategies in Latin America early during the COVID-19 pandemic. Preventive Medicine Reports. febrero de 2022;25(101665):101665. Doi:10.1016/j.pmedr.2021.101665.

Kristoffersen AE, Jong MC, Nordberg JH, van der Werf ET, Stub T. Safety and use of complementary and alternative medicine in Norway during the first wave of the COVID-19 pandemic using an adapted version of the I-CAM-Q; a cross-sectional survey. BMC Complementary Medicine and Therapies. 3 de septiembre de 2022;22(1):234. Doi:10.1186/s12906-022-03656-4.

Parvizi MM, Forouhari S, Shahriarirad R, Shahriarirad S, Bradley RD, Roosta L. Prevalence and associated factors of complementary and integrative medicine use in patients afflicted with COVID-19. BMC Complementary Medicine and Therapies. 30 de septiembre de 2022;22(1):251. Doi: 10.1186/s12906-022-03722-x.

Bussmann RW, Sharon D, Vandebroek I, Jones A, Revene Z. Health for sale: the medicinal plant markets in Trujillo and Chiclayo, Northern Peru. J Ethnobiol Ethnomed. 2007;3:37. Published 2007 Dec 10. Doi:10.1186/1746-4269-3-3.

Published

2024-04-15

How to Cite

1.
Herrera-Añazco P, Toro-Huamanchumo CJ, Nuñez-Tarazona W, Farfán-Zapata O. Association between a history of comorbidities and the use of complementary and alternative medicine to prevent COVID-19. Rev. Cuerpo Med. HNAAA [Internet]. 2024 Apr. 15 [cited 2024 Nov. 22];17(1). Available from: https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/2046

Recommended Articles

<< < 1 2 3 > >>